Abstract: Slide Presentations |

Early Detection of a Second Primary Lung Cancer Enhances Survival in Patients with Known Breast Cancer FREE TO VIEW

Faraz Kerendi, MD*; Joel S. Corvera, MD; Michael E. Halkos, MD; Anthony Gal, MD; Joseph I. Miller, MD
Author and Funding Information

Emory University School of Medicine, Atlanta, GA


Chest. 2004;126(4_MeetingAbstracts):740S. doi:10.1378/chest.126.4_MeetingAbstracts.740S-b
Text Size: A A A
Published online


PURPOSE:  In survivors of breast cancer who subsequently develop a lung nodule, distinguishing between a metastatic breast cancer and a new primary lung carcinoma is critical in determining the proper treatment. This study outlines diagnostic approaches and therapeutic outcomes of such patients and identifies risk factors that adversely correlate with survival.

METHODS:  From 1977 through 2002, out of 5000 patients treated for breast cancer, 35 were identified with a synchronous or metachronous lung cancer. Data collected retrospectively included risk factors, presenting symptoms, diagnostic methods, histopathology, management, and survival. Median survival time and 2 year survival rate were determined by the Kaplan-Meier method and the log rank test. The relative risk (RR) derived from Cox regression was used to assess combinations of risk factors for their association with poor survival.

RESULTS:  Nineteen patients (54%) were asymptomatic at the time of diagnosis and had their lung cancer discovered during workup and/or follow-up of their breast cancer. Thirty patients (85.7%) had non-small cell carcinoma - adenocarcinoma (31%) and squamous cell carcinoma (29%) were the most frequent histologic subtypes. The correct diagnosis of lung cancer was made preoperatively in 23 patients (82%). Nineteen patients (54%) were successfully treated with surgery. Mean follow up was 2.3 years. Median survival for all patients was 1.8 years. Factors associated with a statistically significant improvement in 2 year survival included asymptomatic presentation of lung cancer (P = 0.003), absence of tobacco use (P = 0.021), and lung cancer stage Ia or Ib (P = 0.009). Multivariate analysis revealed that tobacco use (RR = 3.6, P = 0.047) and advanced stage of lung cancer (II-IV) at the time of diagnosis (RR = 2.2, P < 0.001) were independent predictors of decreased survival.

CONCLUSION:  The finding of a lung nodule in patients with breast cancer warrants a comprehensive evaluation, including tissue biopsy, to differentiate between primary lung and metastatic breast cancers.

CLINICAL IMPLICATIONS:  Diagnosis and resection of a second primary lung cancer in the early stages can lead to improved survival.

DISCLOSURE:  F. Kerendi, None.

Tuesday, October 26, 2004

10:30 AM- 12:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Como International Conference Position Statement*: Lung Cancer Screening for Early Diagnosis 5 Years After The 1998 Varese Conference
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543